1. Home
  2. TECH vs MTG Comparison

TECH vs MTG Comparison

Compare TECH & MTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • MTG
  • Stock Information
  • Founded
  • TECH 1976
  • MTG 1957
  • Country
  • TECH United States
  • MTG United States
  • Employees
  • TECH N/A
  • MTG N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • MTG Property-Casualty Insurers
  • Sector
  • TECH Health Care
  • MTG Finance
  • Exchange
  • TECH Nasdaq
  • MTG Nasdaq
  • Market Cap
  • TECH 7.8B
  • MTG 6.4B
  • IPO Year
  • TECH 1989
  • MTG 1991
  • Fundamental
  • Price
  • TECH $54.89
  • MTG $26.27
  • Analyst Decision
  • TECH Buy
  • MTG Hold
  • Analyst Count
  • TECH 12
  • MTG 8
  • Target Price
  • TECH $70.00
  • MTG $26.88
  • AVG Volume (30 Days)
  • TECH 2.1M
  • MTG 2.4M
  • Earning Date
  • TECH 08-06-2025
  • MTG 07-30-2025
  • Dividend Yield
  • TECH 0.58%
  • MTG 2.28%
  • EPS Growth
  • TECH N/A
  • MTG 12.94
  • EPS
  • TECH 0.83
  • MTG 3.05
  • Revenue
  • TECH $1,208,770,000.00
  • MTG $1,218,572,000.00
  • Revenue This Year
  • TECH $7.07
  • MTG $2.92
  • Revenue Next Year
  • TECH $5.72
  • MTG $3.06
  • P/E Ratio
  • TECH $66.02
  • MTG $8.62
  • Revenue Growth
  • TECH 4.72
  • MTG 3.26
  • 52 Week Low
  • TECH $46.01
  • MTG $21.94
  • 52 Week High
  • TECH $83.33
  • MTG $28.67
  • Technical
  • Relative Strength Index (RSI)
  • TECH 52.65
  • MTG 53.11
  • Support Level
  • TECH $49.71
  • MTG $25.27
  • Resistance Level
  • TECH $60.06
  • MTG $25.88
  • Average True Range (ATR)
  • TECH 2.12
  • MTG 0.41
  • MACD
  • TECH 0.05
  • MTG 0.07
  • Stochastic Oscillator
  • TECH 50.05
  • MTG 94.90

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About MTG MGIC Investment Corporation

MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.

Share on Social Networks: